Screener
PAVE vs GNOM
Global X U.S. Infrastructure Development ETF vs Global X Genomics & Biotechnology ETF
Key differences
- PAVE is significantly larger than GNOM — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, PAVE has delivered higher annualized returns.
Side-by-side comparison
| PAVE | GNOM | |
|---|---|---|
| Annual cost (TER) | 0.47% | 0.50% |
| Fund size (AUM) | $13.4B | $51M |
| Since | 2017 | 2019 |
| Dividend yield | 0.77% | 1.38% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +39.0% | +57.9% |
| CAGR 3Y | +27.3% | -1.5% |
| CAGR 5Y | +17.8% | -10.0% |
| Sharpe 3Y | 1.11 | -0.02 |
| Volatility 1Y | 18.91% | 26.22% |
| Max drawdown | -44.08% | -75.00% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PAVE and GNOM
Explore further